FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118103678> ?p ?o ?g. }

• W2118103678 endingPage "235" @default.
• W2118103678 startingPage "223" @default.
• W2118103678 abstract "It has been suggested that interleukin-4 and -5 (IL-4 and IL-5) are instrumental in the control of allergic disease. Elevated levels of IL-4 messenger RNA (mRNA) have been detected in numerous foci of atopic activity, including bronchoalveolar lavage (BAL) fluid from atopic asthmatics and skin of atopic dermatitis patients. IL-5 is important in eosinophil activation, which is a common feature of atopic disease. IL-5 mRNA has been detected in BAL fluid from both atopic and non-atopic asthmatics, indicating that IL-5 may be a common feature of the two disease states. Production of IL-4 and IL-5 by T cells appears to be associated with a high affinity cyclic AMP (cAMP) phosphodiesterase (PDE). This study was designed to compare the effects of PDE inhibitors Ro20-1724 and theophylline on (1) the mitogenic response of peripheral blood mononuclear cells from atopic and non-atopic individuals and (2) secretion of IL-4 and IL-5 by TH2 cells after activation with PMA and anti-CD3. Both Ro20-1724 and theophylline inhibited proliferation of PBMC in a dose-dependent manner. There was no significant difference between proliferation of PBMC from atopic versus non-atopic donors, but Ro20-1724, a specific PDE IV inhibitor, was more potent at a concentration of 10−5M than theophylline in suppressing lymphocyte proliferation. Similarly, both PDE inhibitors suppressed secretion of IL-4 and IL-5 from TH2-like cell lines in a dose-dependent manner. In conclusion, as Ro20-1724 and theophylline inhibit proliferation of PBMC and secretion of IL-4 and IL-5 from human TH 2 cell lines, the development of a selective cyclic nucleotide PDE IV inhibitor may provide a promising new approach for asthma prophylaxis." @default.
• W2118103678 created "2016-06-24" @default.
• W2118103678 creator A5010981502 @default.
• W2118103678 creator A5079660982 @default.
• W2118103678 creator A5087846998 @default.
• W2118103678 date "1996-03-01" @default.
• W2118103678 modified "2023-09-23" @default.
• W2118103678 title "Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells" @default.
• W2118103678 cites W1516350423 @default.
• W2118103678 cites W1968133040 @default.
• W2118103678 cites W1988620870 @default.
• W2118103678 cites W1997541655 @default.
• W2118103678 cites W1998768970 @default.
• W2118103678 cites W2009470926 @default.
• W2118103678 cites W2029916679 @default.
• W2118103678 cites W2035897315 @default.
• W2118103678 cites W2048556479 @default.
• W2118103678 cites W2049192788 @default.
• W2118103678 cites W2064995951 @default.
• W2118103678 cites W2080515070 @default.
• W2118103678 cites W2083010777 @default.
• W2118103678 cites W2086475741 @default.
• W2118103678 cites W2095351296 @default.
• W2118103678 cites W2112667627 @default.
• W2118103678 cites W2125678331 @default.
• W2118103678 cites W2147743799 @default.
• W2118103678 cites W2151820072 @default.
• W2118103678 cites W2160572043 @default.
• W2118103678 cites W2164508592 @default.
• W2118103678 doi "https://doi.org/10.1016/0162-3109(95)00053-4" @default.
• W2118103678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8861748" @default.
• W2118103678 hasPublicationYear "1996" @default.
• W2118103678 type Work @default.
• W2118103678 sameAs 2118103678 @default.
• W2118103678 citedByCount "57" @default.
• W2118103678 countsByYear W21181036782012 @default.
• W2118103678 countsByYear W21181036782019 @default.
• W2118103678 crossrefType "journal-article" @default.
• W2118103678 hasAuthorship W2118103678A5010981502 @default.
• W2118103678 hasAuthorship W2118103678A5079660982 @default.
• W2118103678 hasAuthorship W2118103678A5087846998 @default.
• W2118103678 hasConcept C126322002 @default.
• W2118103678 hasConcept C134018914 @default.
• W2118103678 hasConcept C137061746 @default.
• W2118103678 hasConcept C181199279 @default.
• W2118103678 hasConcept C181901479 @default.
• W2118103678 hasConcept C202751555 @default.
• W2118103678 hasConcept C203014093 @default.
• W2118103678 hasConcept C2776042228 @default.
• W2118103678 hasConcept C2776958096 @default.
• W2118103678 hasConcept C2777037409 @default.
• W2118103678 hasConcept C2777371288 @default.
• W2118103678 hasConcept C2777761686 @default.
• W2118103678 hasConcept C2778095195 @default.
• W2118103678 hasConcept C2778690821 @default.
• W2118103678 hasConcept C49039625 @default.
• W2118103678 hasConcept C49382859 @default.
• W2118103678 hasConcept C55493867 @default.
• W2118103678 hasConcept C62826618 @default.
• W2118103678 hasConcept C71924100 @default.
• W2118103678 hasConcept C74172505 @default.
• W2118103678 hasConcept C86803240 @default.
• W2118103678 hasConcept C8891405 @default.
• W2118103678 hasConceptScore W2118103678C126322002 @default.
• W2118103678 hasConceptScore W2118103678C134018914 @default.
• W2118103678 hasConceptScore W2118103678C137061746 @default.
• W2118103678 hasConceptScore W2118103678C181199279 @default.
• W2118103678 hasConceptScore W2118103678C181901479 @default.
• W2118103678 hasConceptScore W2118103678C202751555 @default.
• W2118103678 hasConceptScore W2118103678C203014093 @default.
• W2118103678 hasConceptScore W2118103678C2776042228 @default.
• W2118103678 hasConceptScore W2118103678C2776958096 @default.
• W2118103678 hasConceptScore W2118103678C2777037409 @default.
• W2118103678 hasConceptScore W2118103678C2777371288 @default.
• W2118103678 hasConceptScore W2118103678C2777761686 @default.
• W2118103678 hasConceptScore W2118103678C2778095195 @default.
• W2118103678 hasConceptScore W2118103678C2778690821 @default.
• W2118103678 hasConceptScore W2118103678C49039625 @default.
• W2118103678 hasConceptScore W2118103678C49382859 @default.
• W2118103678 hasConceptScore W2118103678C55493867 @default.
• W2118103678 hasConceptScore W2118103678C62826618 @default.
• W2118103678 hasConceptScore W2118103678C71924100 @default.
• W2118103678 hasConceptScore W2118103678C74172505 @default.
• W2118103678 hasConceptScore W2118103678C86803240 @default.
• W2118103678 hasConceptScore W2118103678C8891405 @default.
• W2118103678 hasIssue "2-3" @default.
• W2118103678 hasLocation W21181036781 @default.
• W2118103678 hasLocation W21181036782 @default.
• W2118103678 hasOpenAccess W2118103678 @default.
• W2118103678 hasPrimaryLocation W21181036781 @default.
• W2118103678 hasRelatedWork W2013270686 @default.
• W2118103678 hasRelatedWork W2021166509 @default.
• W2118103678 hasRelatedWork W2023599848 @default.
• W2118103678 hasRelatedWork W2069263260 @default.
• W2118103678 hasRelatedWork W2078402260 @default.
• W2118103678 hasRelatedWork W2118103678 @default.
• W2118103678 hasRelatedWork W2183376808 @default.
• W2118103678 hasRelatedWork W2278889711 @default.

• next